Melatonin taken as a supplement. This page lists the registered trials that test it, condition by condition, with each trial's status on ClinicalTrials.gov.
Trials by condition
Sorted by number of trials. Within a condition, trials with posted results come first, then completed, recruiting and active ones. The condition name opens its evidence-gap map.
What these trials measure
Primary outcomes, grouped by keyword rules: Sleep (24), Symptom severity and disease activity (18), Inflammation and other biomarkers (9), Clinical events, survival and healthcare use (8), Mood, anxiety and wellbeing (5), Pain (5), Heart rate, blood pressure and autonomic (4), Feasibility, adherence and safety (4), Cognition (4), Breathing and lung function (2), Physical function and exercise capacity (2), Weight and metabolic markers (2), Fatigue and energy (1), Quality of life (1).
Names used for this class in the registry
melatonin, inhaled melatonin (100 μg), melatonin(circadin®), melatonin (n-acetyl-5-methoxytryptamine), melatonin patches, group 3: melatonin group, therapeutic melatonin, melatonin oral gel 3%, experimental: melatonin treatment group, melatonin ("circadin"), low dose melatonin, high dose melatonin
Download all 81 trials (CSV) All non-drug classes
Related in Supplements and nutraceuticals: Vitamin D · Omega-3 fatty acids and fish oil · Probiotics, prebiotics and synbiotics · Coenzyme Q10 · NAD+ precursors (nicotinamide riboside, NMN) · N-acetylcysteine · Magnesium · Zinc · Creatine · Vitamin C · B vitamins and folate · Curcumin and other polyphenols · Amino acids and protein supplements · Herbal medicines and traditional formulas · Other vitamins, minerals and multivitamins · Other supplements and nutraceuticals
Source: ClinicalTrials.gov, searched 2026-11-16. Classification rules and exclusions: how this map is built.